Cell-specific mineralocorticoid receptors:future therapeutic targets for stroke?

被引：0

作者：

Quynh N.Dinh ^{[1
]}

Grant R.Drummond ^{[1
]}

Christopher G.Sobey ^{[1
]}

Sophocles Chrissobolis ^{[2
]}

机构：

[1] Vascular Biology & Immunopharmacology Group,Cardiovascular Disease Program and Department of Pharmacology,Biomedicine Discovery Institute,Monash University

[2] Department of Pharmaceutical and Biomedical Sciences,Raabe College of Pharmacy,Ohio Northern University

来源：

Neural Regeneration Research | 2016年 / 11卷 / 08期

基金：

英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;

关键词：

MR; MCAO;

D O I：

暂无

中图分类号：

R977 [影响生长代谢机能药物];

学科分类号：

摘要：

The mineralocorticoid receptor(MR),well known to be expressed in renal epithelial cells where it is important in fluid and electrolyte homeostasis,has aldosterone as one of its main agonists.Much research in the last 10–15 years indicates that MRs are also expressed outside of the kidney,including in the brain,vasculature and heart,where they contribute to the pathophysiology of disease(Dinh et al.,2012

引用

页码：1230 / 1231

页数：2

共 50 条

[1] Cell-specific mineralocorticoid receptors: future therapeutic targets for stroke?
Dinh, Quynh N.
Drummond, Grant R.
Sobey, Christopher G.
Chrissobolis, Sophocles
NEURAL REGENERATION RESEARCH, 2016, 11 (08) : 1230 - 1231
[2] Vascular cell-specific roles of mineralocorticoid receptors in pulmonary hypertension
Menon, Divya P.
Qi, Guanming
Kim, Seung K.
Moss, M. Elizabeth
Penumatsa, Krishna C.
Warburton, Rod R.
Toksoz, Deniz
Wilson, Jamie
Hill, Nicholas S.
Jaffe, Iris Z.
Preston, Ioana R.
PULMONARY CIRCULATION, 2021, 11 (03)
[3] Renal principal cell-specific mutation of the mineralocorticoid receptor
Ronzaud, C
Berger, S
FASEB JOURNAL, 2005, 19 (04): : A157 - A157
[4] Hepatic fibrosis:It is time to go with hepatic stellate cell-specific therapeutic targets
Devaraj Ezhilarasan
Etienne Sokal
Mustapha Najimi
Hepatobiliary&PancreaticDiseasesInternational, 2018, 17 (03) : 192 - 197
[5] Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets
Ezhilarasan, Devaraj
Sokal, Etienne
Najimi, Mustapha
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2018, 17 (03) : 192 - 197
[6] BRAIDing receptors for cell-specific targeting
Chen, Hui
Lee, Sung-Jin
Li, Ryan
Sura, Asmiti
Suen, Nicholas
Dilip, Archana
Pomogov, Yan
Vuppalapaty, Meghah
Suen, Timothy T.
Lu, Chenggang
Post, Yorick
Li, Yang
ELIFE, 2024, 12
[7] Cell-specific regulation of mineralocorticoid receptor signalling in cardiovascular disease
Young, Morag J.
ENDOCRINE JOURNAL, 2010, 57 : S304 - S304
[8] Chemokine receptors - Future therapeutic targets for HIV!
Proudfoot, AEI
Wells, TNC
Clapham, PR
BIOCHEMICAL PHARMACOLOGY, 1999, 57 (05) : 451 - 463
[9] Cell-specific, promoter-dependent mineralocorticoid agonist activity of spironolactone
Massaad, C
Lombes, M
Aggerbeck, M
RafestinOblin, ME
Barouki, R
MOLECULAR PHARMACOLOGY, 1997, 51 (02) : 285 - 292
[10] IDENTIFICATION OF AML STEM CELL-SPECIFIC THERAPEUTIC TARGETS IN AN IN VIVO MODEL OF HUMAN PRIMARY AML
Saito, Y.
Kitamura, H.
Hijikata, A.
Tomizawa-Murasawa, M.
Tanaka, S.
Takagi, S.
Uchida, N.
Suzuki, N.
Sone, A.
Najima, Y.
Ozawa, H.
Wake, A.
Taniguchi, S.
Shultz, L. D.
Ohara, O.
Ishikawa, F.
EXPERIMENTAL HEMATOLOGY, 2010, 38 (09) : S44 - S44

← 1 2 3 4 5 →